{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:52:49Z","timestamp":1783338769764,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>ExtraCorporeal Liver Support (ECLS) systems were developed with the aim of supporting the liver in its detoxification function by clearing the blood from hepatic toxic molecules. We conducted a retrospective comparative analysis on patients presenting with liver failure who were treated with different extracorporeal techniques in our intensive care unit to evaluate and compare their detoxification abilities. To verify the effectiveness of the techniques, mass balance (MB) and adsorption per hour were calculated for total bilirubin (TB), direct bilirubin (DB), and bile acids (BA) from the concentrations measured. MB represents the total amount (mg or mcMol) of a molecule removed from a solution and is the only representative parameter to verify the purification effectiveness of one system as it is not affected by the continuous production of the molecules, released in the circulation from the tissues, as it is the case for the reduction rate (RR). The total adsorption per hour is calculated by the ratio between MB and the time duration and shows the adsorption ability in an hour. Our comparative study shows the superior adsorption capability of CytoSorb system regarding TB, DB, and BA, evaluated through the MB and adsorption per hour, in comparison with CPFA, MARS, Prometheus, and PAP. In conclusion, as extracorporeal purification in liver failure could be considered useful for therapeutic purposes, Cytosorb, being more performing than other systems considered, could represent the device of first choice.<\/jats:p>","DOI":"10.1007\/s10047-023-01409-9","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T09:02:07Z","timestamp":1687165327000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Extracorporeal liver support techniques: a comparison"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0518-0891","authenticated-orcid":false,"given":"Ivano","family":"Riva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino Martino","family":"Valetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmariano","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fabretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4161\/org.7.1.14069","volume":"7","author":"J Stange","year":"2011","unstructured":"Stange J. Extracorporeal liver support. Organogenesis. 2011;7:64\u201373.","journal-title":"Organogenesis"},{"key":"1409_CR2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/bm701396n","volume":"9","author":"V Weber","year":"2008","unstructured":"Weber V, Linsberger I, Hauner M, Leistner A, Leistner A, Falkenhagen D. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure. Biomacromol. 2008;9:1322\u20138.","journal-title":"Biomacromol"},{"key":"1409_CR3","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1038\/sj.jp.7210634","volume":"21","author":"TW Hansen","year":"2001","unstructured":"Hansen TW. Bilirubin brain toxicity. J Perinatol. 2001;21:S48\u201355.","journal-title":"J Perinatol"},{"key":"1409_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jceh.2018.06.007","volume":"8","author":"AR Jayakumar","year":"2018","unstructured":"Jayakumar AR, Norenberg MD. Hyperammonemia in hepatic encephalopathy. J Clin Exp Hepatolol. 2018;8:272\u2013328.","journal-title":"J Clin Exp Hepatolol"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/jn\/137.6.1579S","volume":"137","author":"H Cornelis","year":"2007","unstructured":"Cornelis H, Dejong C, Marcel CG, et al. Aromatic amino acid metabolism during liver failure. J Nutr. 2007;137:1579\u201385.","journal-title":"J Nutr"},{"key":"1409_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/jnnp.63.3.279","volume":"63","author":"EA Jones","year":"1997","unstructured":"Jones EA, Weissenborn K. Neurology and the liver. J Neurol Neurosurg Psychiatry. 1997;63:279\u201393.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1409_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/HMER.S6918","volume":"2","author":"P Angeli","year":"2010","unstructured":"Angeli P, Morando F. Optimal management of hepatorenal syndrome in patients with cirrhosis. Hepat Med. 2010;2:87\u201398.","journal-title":"Hepat Med"},{"key":"1409_CR8","first-page":"229","volume":"19","author":"MG Betjes","year":"2006","unstructured":"Betjes MG, Bajema I. The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited. J Nephrol. 2006;19:229\u201333.","journal-title":"J Nephrol"},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ki.2013.78","volume":"84","author":"CM van Slambrouck","year":"2013","unstructured":"van Slambrouck CM, Salem F, Meehan SM, Chang A. Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. Kidney Int. 2013;84:192\u20137.","journal-title":"Kidney Int"},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.bbadis.2017.08.028","volume":"1864","author":"E Krones","year":"2018","unstructured":"Krones E, Marion JP, Rosenkranzc AR, Fickert P. Cholemic nephropathy\u2014historical notes and novel perspectives. Mol Basis Dis. 2018;1864:1356\u201366.","journal-title":"Mol Basis Dis"},{"key":"1409_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11882-010-0117-z","volume":"10","author":"MW Greaves","year":"2010","unstructured":"Greaves MW. Pathogenesis\u00a0and\u00a0treatment\u00a0of\u00a0pruritus. Curr Allergy Asthma Rep. 2010;10:236\u201342.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1409_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1478-3231.2011.02588.x","volume":"31","author":"P Krisper","year":"2011","unstructured":"Krisper P, Stadlbauer V, Stauber RE. Clearing of toxic substances: are there differences between the available liver support devices? Liver Int. 2011;31:5\u20138.","journal-title":"Liver Int"},{"key":"1409_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000102130","volume":"156","author":"A Santoro","year":"2007","unstructured":"Santoro A, Mancini E, Ferramosca E, Faenza S. Liver support systems. Contrib Nephrol. 2007;156:396\u2013404.","journal-title":"Contrib Nephrol"},{"key":"1409_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S1665-2681(19)31602-3","volume":"10","author":"S Mitzner","year":"2011","unstructured":"Mitzner S. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Ann Hepatol. 2011;10:S21\u20138.","journal-title":"Ann Hepatol"},{"key":"1409_CR15","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.1016\/S0168-8278(10)61185-3","volume":"52","author":"R Banares","year":"2010","unstructured":"Banares R, Nevens F, Larsen F, et al. Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (The RELIEF trial). J Hepatol. 2010;52:S459\u2013S459.","journal-title":"J Hepatol"},{"key":"1409_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","volume":"142","author":"A Kribben","year":"2012","unstructured":"Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782\u20139.","journal-title":"Gastroenterology"},{"key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.transproceed.2007.05.010","volume":"9","author":"GL Adani","year":"2007","unstructured":"Adani GL, Lorenzin D, Curr\u00f2 G, et al. Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction. Transplant Proc. 2007;9:1904\u20136.","journal-title":"Transplant Proc"},{"key":"1409_CR18","unstructured":"De Simone W, Crafa F, Noviello A, et al. Bilirubin\u00a0removal with coupled plasma filtration and adsorption in patients affected by hilar cholangiocarcinoma. G Ital Nefrol. 2017;34."},{"key":"1409_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003536","volume":"4","author":"S Livigni","year":"2014","unstructured":"Livigni S, Bertolini G, Rossi C, et al. \u2019Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomized controlled clinical trial\u2019. BMJ Open. 2014;4: e003536.","journal-title":"BMJ Open"},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000492378","volume":"47","author":"C Gemelli","year":"2019","unstructured":"Gemelli C, Cuoghi A, Magnani S, et al. Removal of bilirubin with a new adsorbent system: in vitro kinetics. Blood Purif. 2019;47:10\u20135.","journal-title":"Blood Purif"},{"key":"1409_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5301\/ijao.5000489","volume":"39","author":"DR Tomescu","year":"2016","unstructured":"Tomescu DR, Dima SO, Ungureanu D, Popescu M, Tulbure D, Popescu I. First report of cytokine removal using CytoSorb in severe noninfectious inflammatory syndrome after liver transplantation. Int J Artif Organs. 2016;39:136\u201340.","journal-title":"Int J Artif Organs"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/aor.13327","volume":"43","author":"MG Calabr\u00f2","year":"2019","unstructured":"Calabr\u00f2 MG, Febres D, Recca G, et al. Blood purification with Cytosorb in critically ill patients: single-center preliminary experience. Artif Organs. 2019;43:189\u201394.","journal-title":"Artif Organs"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2005.02.038","volume":"43","author":"P Krisper","year":"2005","unstructured":"Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractioned plasma separation. J Hepatol. 2005;43:451\u20137.","journal-title":"J Hepatol"},{"key":"1409_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10047-017-0986-1","volume":"21","author":"D Viggiano","year":"2018","unstructured":"Viggiano D, de Pascale E, Marinelli G, Pluvio C. A comparison among three different apheretic techniques for treatment of hyperbilirubinemia. J Artif Organs. 2018;21:110\u20136.","journal-title":"J Artif Organs"},{"key":"1409_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/01.mat.0000249852.71634.6c","volume":"53","author":"V Stadlbauer","year":"2007","unstructured":"Stadlbauer V, Krisper P, Beuers U, et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J. 2007;53:187\u201393.","journal-title":"ASAIO J"},{"key":"1409_CR26","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1515\/CCLM.2006.164","volume":"44","author":"AJ Bakker","year":"2006","unstructured":"Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PHJ. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionized and total\/ionized calcium. Clin Chem Lab Med. 2006;44:962\u20136.","journal-title":"Clin Chem Lab Med"},{"key":"1409_CR27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/jgh.15255","volume":"36","author":"R Tandon","year":"2021","unstructured":"Tandon R, Froghi S. Artificial liver support systems. J Gast Hep. 2021;36:1164\u201379.","journal-title":"J Gast Hep"},{"key":"1409_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/0391398820981383","volume":"44","author":"D Tomescu","year":"2021","unstructured":"Tomescu D, Popescu M, Dima S. Hemoadsorption by Cytosorb in patients with acute liver failure: a case series. IJAO. 2021;44:560\u20134.","journal-title":"IJAO"},{"key":"1409_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.34067\/KID.0005932020","volume":"360","author":"P Fickert","year":"2022","unstructured":"Fickert P, Rosenkranz AR. Bile acids are important contributors to AKI associated with liver disease: PRO. Kidney. 2022;360:17\u201320.","journal-title":"Kidney"},{"key":"1409_CR30","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.3390\/jcm10215182","volume":"10","author":"K Ocskay","year":"2021","unstructured":"Ocskay K, Tomescu D. Hemoadsorption in \u2018Liver indication\u2019\u2014analysis of 109 patients \u2018Data from the Cytosorb International Registry.\u2019 J Clin Med. 2021;10:5182.","journal-title":"J Clin Med"},{"key":"1409_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-019-05783-y","volume":"46","author":"F Alshamsi","year":"2020","unstructured":"Alshamsi F, Alshammari K, Belley-Cote E, et al. Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med. 2020;46:1\u201316.","journal-title":"Intensive Care Med"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-023-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-023-01409-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-023-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T20:10:31Z","timestamp":1724616631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-023-01409-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s10047-023-01409-9","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}